文献速递神经MRCT

采用MR动态对比增强灌注定义缺血性卒中血管内治疗后的再灌注

Defining reperfusion post endovascular therapy in ischemic stroke using MR-dynamic contrast enhanced perfusion.
PubMed 文献 · Br J Radiol · 2020-09-17

本研究比较血管内治疗后改良脑梗死溶栓评分(mTICI)与MRI动态对比增强灌注在5小时内测量的再灌注,并将灌注参数与mTICI纳入预测模型分析24小时NIHSS变化和DWI病灶增长。结果显示mTICI-2b组与mTICI<2b组急性梗死区灌注值无显著差异,而mTICI-3组与mTICI-2b及<2b组均有统计学显著差异(p=0.02);预测NIHSS变化和DWI病灶绝对体积变化的最佳模型特征分别为急性梗死ROI内rT0和入院CTA侧支循环。

要点

  • mTICI-2b与mTICI<2b组急性梗死区各灌注参数均值无显著差异,而mTICI-3组与两组均有统计学显著差异(p=0.02)。
  • 预测24小时NIHSS变化的最佳模型特征为急性梗死ROI内rT0,mTICI评分未被选入。
  • 预测DWI病灶绝对体积变化的最佳模型特征为入院CTA侧支循环,mTICI评分未被选入。

核心结论

  • 血管内治疗后的MR灌注提供准确的生理学方法以理解脑血流量、临床结局与DWI增长之间的关系。
  • 血管内治疗后获得的MR灌注脑血流量是稳健、客观的再灌注测量,在目标闭塞再通后有助于区分潜在治疗伤害与技术成功失败,并改善临床试验结局对疾病修饰的敏感性。

研究设计与样本

  • 研究比较血管内治疗后5小时内前循环卒中患者的mTICI评分与MRI动态对比增强灌注所量化的再灌注。
  • 将MR灌注参数(rCBF、rCBV、rTmax、rT0)与mTICI评分纳入预测模型,采用机器学习RRELIEFF特征选择结合支持向量回归,预测24小时NIHSS变化和DWI病灶增长(急性期至24小时MRI)。

诊断标准与关键数值

  • mTICI-2b组急性梗死区各灌注参数均值与mTICI<2b组无显著差异。
  • mTICI-3组急性梗死区ROI灌注值与mTICI-2b及<2b组均有统计学显著差异(p=0.02)。
  • 预测24小时NIHSS变化的最佳模型特征为急性梗死ROI内rT0,交叉验证相关系数0.47(均方根误差13.7)。
  • 预测DWI病灶绝对体积变化的最佳模型特征为入院CTA侧支循环,交叉验证相关系数0.51(均方根误差5.7)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Cerebral blood flow (CBF) measurements after endovascular therapy (EVT) for acute ischemic stroke are important to distinguish early secondary injury related to persisting ischemia from that related to reperfusion when considering clinical response and infarct growth.

METHODS: We compare reperfusion quantified by the modified Thrombolysis in Cerebral Infarction Score (mTICI) with perfusion measured by MRI dynamic contrast-enhanced perfusion within 5 h of EVT anterior circulation stroke. MR perfusion (rCBF, rCBV, rTmax, rT0) and mTICI scores were included in a predictive model for change in NIHSS at 24 h and diffusion-weighted imaging (DWI) lesion growth (acute to 24 h MRI) using a machine learning RRELIEFF feature selection coupled with a support vector regression.

RESULTS: For all perfusion parameters, mean values within the acute infarct for the TICI-2b group (considered clinically good reperfusion) were not significantly different from those in the mTICI <2b (clinically poor reperfusion). However, there was a statistically significant difference in perfusion values within the acute infarct region of interest between the mTICI-3 group versus both mTICI-2b and <2b (p = 0.02). The features that made up the best predictive model for change in NIHSS and absolute DWI lesion volume change was rT0 within acute infarct ROI and admission CTA collaterals respectively. No other variables, including mTICI scores, were selected for these best models. The correlation coefficients (Root mean squared error) for the cross-validation were 0.47 (13.7) and 0.51 (5.7) for change in NIHSS and absolute DWI lesion volume change.

CONCLUSION: MR perfusion following EVT provides accurate physiological approach to understanding the relationship of CBF, clinical outcome, and DWI growth.

ADVANCES IN KNOWLEDGE: MR perfusion CBF acquired is a robust, objective reperfusion measurement providing following recanalization of the target occlusion which is critical to distinguish potential therapeutic harm from the failed technical success of EVT as well as improve the responsiveness of clinical trial outcomes to disease modification.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. d'Esterre CD, Sah RG, Assis Z, et al. Defining reperfusion post endovascular therapy in ischemic stroke using MR-dynamic contrast enhanced perfusion. Br J Radiol. 2020. PMID: 32941770. doi:10.1259/bjr.20190890

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。